Bone Growth Stimulator Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators), By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others), By End User (Hospital and Ambulatory Surgery Centers, Home Care Settings, Academic and Research Institutes), By Region

Global bone growth stimulator market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing geriatric population along with the increasing incidences of accidental injuries along with bone disorders across the globe. Additionally, the rising prevalence of arthritis, diabetes-like diseases, and other medical conditions like obesity, vascular diseases, renal disorder and increasing demand for minimally invasive and non-invasive surgical treatments are the major factors driving the growth of the market over the years. Additionally, growing awareness about bone growth stimulators and procedural benefits provided by bone growth stimulators for the treatment of bone fracture and orthopedic diseases is further boosting the market growth during the forecast period. Besides, growing technological advancement in bone growth stimulators and the growing adoption rate for bone growth stimulators by patients and healthcare providers are major factors boosting the market’s growth over the years. Bone growth stimulators work by delivering energy to the site of the injury, which stimulates bone cells to grow and multiply. This process accelerates the healing of the injured bone, reducing the time required for recovery and decreasing the risk of complications such as infections and deformities. Bone growth stimulators have a wide range of applications in orthopedic medicine. They are commonly used in the treatment of non-union fractures, where the bone fails to heal properly after an injury. They are also used in spinal fusions, where two or more vertebrae are fused together to treat conditions such as degenerative disc disease, spinal stenosis, and herniated discs. Many bone growth stimulators are non-invasive and can be used externally without the need for surgery or implants. Studies have shown that bone growth stimulators can be effective in promoting bone healing and growth, particularly in cases of delayed or non-union fractures. Bone growth stimulators can help accelerate the healing process, reducing the amount of time required for bone to heal and reducing the risk of complications. Compared to surgical interventions, bone growth stimulators are often more cost-effective, making them a good option for patients and healthcare systems. Many bone growth stimulators are portable and can be used at home, allowing patients to continue their daily activities while undergoing treatment.

Growing Prevalence of Bone Disorders

The growing occurrence of bone diseases across the globe due to the increasing population is expected to create lucrative growth during the forecast period. Osteoporosis is one of the major diseases that cause fractures across the globe which anticipated the growth of the bone growth stimulator market over the years. More than 8.9 million fractures annually happen and affect around 75 million people in the U.S. In addition, increasing prevalence of osteoarthritis is also expected to boost the market’s growth during the forecast period. The rise in the prevalence and burden of orthopedic diseases has increased the patient pool undergoing minimally invasive surgeries across the globe. So, the demand for bone growth stimulators has increased rapidly. Similarly, the high prevalence of bone marrow transplants and bone cancers adds to the demand for the bone growth stimulator market during the forecast period. The American Cancer Society estimates that cases of primary cancer of the bones and joints for 2022, include 3,910 newly diagnosed cases and about 2,100 deaths. Furthermore, an increasing incidence of trauma and accident cases worldwide is considered one of the major factors likely to boost the demand for the market. According to the National Safety Council, in 2018, around 4.5 million people were severely injured due to accidents. Thus, the above-mentioned factors explain that the bone growth stimulator market is expected to witness significant growth over the forecast period globally. Patients are increasingly seeking non-invasive treatment options that are less painful, require shorter recovery times, and have fewer complications than traditional surgery. Bone growth stimulators offer a non-invasive treatment option for a variety of orthopedic conditions, making them a popular choice for patients. The growing incidence of orthopedic diseases, such as osteoporosis, arthritis, and osteoarthritis, has been a major driver of the bone growth stimulator market. These conditions affect millions of people worldwide and can lead to significant pain and disability. As a result, there is a growing demand for non-invasive treatment options, such as bone growth stimulators.

Growing research and development activities

Increasing efforts from different manufacturers to develop novel and innovative technologically advanced products in the market will significantly boost the market growth during the forecast period. Similarly, the rapid adoption of advanced technology is expected to create lucrative growth during the forecast period. For instance, in March 2016, Bioventus LLC launched its ultrasound bone healing stimulator system. Additionally, increasing demand for minimally invasive surgeries is increasing because of patient benefits like painless treatment, reduced postoperative hospital stay, reduced surgical trauma, surgical risks reduced, improved patient care, and greater affordability is improving the demand for bone growth stimulator market across the globe during the forecast period. According to National Spinal Cord Injury Statistical Centre’s statistics, there are 17,730 new cases of spinal cord injury reported annually, and between 249,000 and 363,000 Americans are estimated to be living with a spinal cord injury. Technological advancements in bone growth stimulator devices have also been a key driver of the market. Newer devices offer greater precision and control, allowing physicians to tailor treatment to the specific needs of each patient. Some bone growth stimulators come equipped with sensors that monitor the healing process in real-time, allowing physicians to adjust treatment as necessary. Bone growth stimulators are increasingly being used in sports medicine to treat injuries such as stress fractures and non-union fractures. This is driving growth in the market as more sports teams and athletes adopt this non-invasive treatment option. There is growing demand for bone growth stimulators in emerging markets such as Asia Pacific and Latin America. This is due to factors such as an aging population, increasing healthcare expenditure, and a growing prevalence of orthopedic conditions. As these markets continue to grow, they will drive demand for bone growth stimulator devices. There have been increasing partnerships and collaborations between companies in the bone growth stimulator market, as well as with healthcare providers and regulatory bodies. These collaborations are driving innovation, improving patient outcomes, and promoting the adoption of bone growth stimulators. Healthcare providers are increasingly focusing on providing patient-centric care, which involves tailoring treatments to meet the specific needs and preferences of individual patients. Bone growth stimulators offer a non-invasive and patient-friendly treatment option that aligns with this focus on patient-centric care, driving demand for these devices. Orthofix Spinal-Stim - This is a non-invasive bone growth stimulator designed for spinal fusion surgeries. It uses electromagnetic fields to stimulate bone growth. Exogen Ultrasound Bone Healing System - This is a portable, non-invasive device that uses low-intensity pulsed ultrasound to stimulate bone growth. It is used to accelerate healing in fractures that have not healed properly. DJO Global CMF SpinaLogic - This is another bone growth stimulator designed for spinal fusion surgeries. It uses electrical stimulation to promote bone growth.

Recent Development

• In 2020, Orthofix launched its PhysioStim bone growth stimulator. The device uses low-intensity ultrasound technology to stimulate bone growth and is designed to treat non-healing fractures.
• In 2019, Zimmer Biomet launched the EBI Bone Healing System, a non-invasive device that uses pulsed electromagnetic fields to promote bone growth. The device is designed to treat fractures and promote bone healing after spinal fusion surgery.
• In 2018, Ossatec launched the Ossatec Stratos, a portable bone growth stimulator that uses low-intensity pulsed ultrasound technology to promote bone healing. The device is designed to be used at home and is intended to treat fractures and promote bone healing after surgery.
• In August 2021, Bioventus announced that it had received FDA approval for its newest bone growth stimulator, the Exogen X2. This device is designed to promote bone healing in fractures and non-unions, and it features a new, intuitive interface and improved battery life.
• In June 2021, Orthofix announced that it had launched a new version of its Spinal-Stim bone growth stimulator. The Spinal-Stim with Smart-Start technology is designed to automatically detect when it is properly placed on the patient's skin and to begin treatment without any manual adjustments.
• In May 2021, Stryker announced that it had received FDA clearance for its new bone growth stimulator, the BoneScalpel Ultrasonic System. This device uses ultrasonic energy to cut and remove bone tissue, and it is designed to be more precise and efficient than traditional surgical tools.

Download Free Sample Report

Market Segmentation

Global bone growth stimulator market can be segmented by type, application, end-user, and region. Based on type, the market can be segmented into External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, and Implanted Bone Growth Stimulators. Based on application, the market can be grouped into Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, and Others. Based on end users, the market can be segmented into Hospital and Ambulatory Surgery Centers, Home Care Settings, and Academic and Research Institutes. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among these different countries, the United States dominated the global bone growth stimulator market on account of the growing demand for minimally invasive surgeries with low costs for the treatment of bone-related diseases.

Market Players

Colfax Corporation., Arthrex., Essex Woodlands Healthcare Partners., Isto Biologics., JOHNSON and JOHNSON., Medtronic Plc., Orthofix Medical Inc., Stryker Corporation., Terumo Corporation, Zimmer Biomet Holdings., Manamed Inc., Theragen Etex Co. Ltd. are some of the leading players operating in the Global Bone Growth Stimulators Market.

Report Scope:

In this report, the global bone growth stimulator market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Bone Growth Stimulator Market, By Type:

o    External Bone Growth Stimulators

o    Ultrasonic Bone Growth Stimulators

o    Implanted Bone Growth Stimulators

• Bone Growth Stimulator Market, By Application:

o    Spinal Fusion Surgeries

o    Delayed Union, and Non-union Bone Fractures

o    Oral and Maxillofacial Surgeries

o    Others

• Bone Growth Stimulator Market, By End Users:

o    Hospital and Ambulatory Surgery Centers

o    Home Care Settings

o    Academic and Research Institutes

• Bone Growth Stimulator Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bone Growth Stimulator Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Bone Growth Stimulator Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]